The Leerink analysts expect CagriSema to demonstrate best-ever weight loss any day now, adding that we expect at least high-20% weight loss. Still, CagriSema could pose practical challenges for Novo, particularly in terms of commercialization
Varela MC, Kok F, Setian N, Kim CA, Koiffmann CP : Impact of molecular mechanisms, including deletion size, on Prader-Willi syndrome phenotype: study of 75 patients
Immunol Cell Biol 80:550557 Kim SM, Ha JS, Han AR, Cho SW, Yang SJ (2019) Effects of -lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation
Clinicians at Found decide dosing schedules based on the unique traits of a patients biology and medical history. Those with a medical contraindication or those who need a full dosage to be effective may be advised against microdosing
However, this association was not observed at the 50 mg dose, and the analysis was based on only two trials with limited sample sizes